Experience

Third Pole Therapeutics

• United States
• Medical Equipment Manufacturing
• 1 - 100 Employee

• Product Manager

  • Feb 2020 - Present

  Capable of generating nitric oxide from air and electricity on-demand and on-site, Third Pole platform is a software / hardware technology accessible to patients and clinicians in both the hospital and home settings. Capable of generating nitric oxide from air and electricity on-demand and on-site, Third Pole platform is a software / hardware technology accessible to patients and clinicians in both the hospital and home settings.



Convergent Dental

• United States
• Medical Equipment Manufacturing
• 1 - 100 Employee

• Product Manager

  • May 2017 - Feb 2020

  Managed software for Solea Laser, used for oral procedures. Managed strategic roadmap; launched11 software updates.

• Product Development Engineer

  • Sep 2016 - May 2017

  Convergent Dental, is a technology company and developer of Solea™, the world’s first computer-aided, CO2 laser system to ever be cleared by the FDA for both hard and soft tissue indications. Solea™ is a software / hardware technology used in clinic settings.



Sitters Without Borders

• Education
• 1 - 100 Employee

• Founder, Board President

  • Mar 2014 - Jul 2017

  Founded a successful first-of-its-kind nonprofit, which provides free 4-hr-babysitting session to low-income mothers attending college, via volunteer sitters. Built relationships with 25+ universities/organizations. Recruited & managed staff and board members. Featured in Boston Globe, Redbook Magazine, IMBoston. Founded a successful first-of-its-kind nonprofit, which provides free 4-hr-babysitting session to low-income mothers attending college, via volunteer sitters. Built relationships with 25+ universities/organizations. Recruited & managed staff and board members. Featured in Boston Globe, Redbook Magazine, IMBoston.



Acorda Therapeutics, Inc.

• United States
• Biotechnology Research
• 100 - 200 Employee

• Medical Device Engineer II

  • May 2015 - Jul 2016

  Development of 3 medical devices in Phases I, III and concept: self-administered drug delivery through inhalers and other inhalation systems. Development of 3 medical devices in Phases I, III and concept: self-administered drug delivery through inhalers and other inhalation systems.



CytoVera, Inc.

• Product Development Specialist

  • 2012 - 2015

  Developed and optimized biomedical devices (capital equipment) for stem cell isolation from Stromal Vascular Fraction (SVF) and Cord Blood, for research and clinical use. Developed and optimized biomedical devices (capital equipment) for stem cell isolation from Stromal Vascular Fraction (SVF) and Cord Blood, for research and clinical use.


Dana-Farber Cancer Institute
• United States
• Hospitals and Health Care
• 700 & Above Employee
• Clinical Research Coordinator Intern

  • Jul 2010 - Sep 2011